Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27,795,576
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
294,235
-
Shares change
-
-37,787
-
Total reported value, excl. options
-
$1,153,398
-
Value change
-
-$24,627
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$3.92
Significant Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q4 2023
4 filings reported holding AXDX - Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share as of Q4 2023.
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 294,235 shares
of 27,795,576 outstanding shares and own 1.1% of the company stock.
Largest 4 shareholders include Birchview Capital, LP (225,239 shares), CHARTIST INC /CA/ (68,996 shares), Northwest Bank & Trust Co (0 shares), and Destiny Capital Corp/CO (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.